HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sabine André Selected Research

Squamous Cell Carcinoma of Head and Neck

7/2014Expression of Galectins 1, 3 and 9 in normal oral epithelium, oral squamous papilloma, and oral squamous cell carcinoma.
12/2012Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors.
9/2010Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma.
7/2006Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sabine André Research Topics

Disease

60Neoplasms (Cancer)
12/2016 - 01/2002
14Carcinoma (Carcinomatosis)
01/2017 - 12/2002
9Neuroblastoma
02/2016 - 01/2002
8Colonic Neoplasms (Colon Cancer)
12/2016 - 01/2004
5Inflammation (Inflammations)
02/2016 - 06/2004
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2012 - 03/2002
4Disease Progression
10/2022 - 08/2004
4Osteoarthritis
10/2022 - 10/2014
4Wounds and Injuries (Trauma)
01/2016 - 01/2011
4Squamous Cell Carcinoma of Head and Neck
07/2014 - 07/2006
4Carcinogenesis
07/2014 - 01/2005
4Pancreatic Neoplasms (Pancreatic Cancer)
11/2012 - 07/2007
3Hypopharyngeal Neoplasms
02/2009 - 07/2006
3Laryngeal Neoplasms (Laryngeal Cancer)
01/2009 - 05/2007
3Neoplasm Metastasis (Metastasis)
08/2006 - 06/2002
2Lymphatic Metastasis
08/2013 - 08/2005
2Autoimmune Diseases (Autoimmune Disease)
01/2013 - 10/2012
2Proliferative Vitreoretinopathy
03/2011 - 10/2009
2Hypertrophy
02/2009 - 11/2004
2Heart Failure
02/2009 - 11/2004
2Squamous Cell Neoplasms (Squamous Cell Cancer)
08/2005 - 10/2004
2Craniopharyngioma (Craniopharyngiomas)
04/2005 - 03/2002
2Colorectal Neoplasms (Colorectal Cancer)
08/2004 - 06/2002
1Starvation
12/2016
1Virus Diseases (Viral Diseases)
12/2016
1Lymphoma (Lymphomas)
10/2016
1Multiple Myeloma
10/2016
1Dehydration (Water Stress)
03/2016
1Acanthamoeba Keratitis
01/2016
1Papilloma (Papillomatosis)
07/2014
1Rheumatoid Arthritis
03/2014
1Margins of Excision
02/2013
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2013
1Rheumatic Diseases (Rheumatism)
01/2013
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2013

Drug/Important Bio-Agent (IBA)

39Galectins (Galectin)IBA
10/2022 - 01/2002
36LectinsIBA
10/2022 - 01/2002
29Galectin 1 (LGALS1)IBA
12/2016 - 01/2002
22Galectin 3 (LGALS3)IBA
12/2016 - 01/2002
15Polysaccharides (Glycans)IBA
10/2022 - 08/2004
12CarbohydratesIBA
07/2015 - 09/2003
9Proteins (Proteins, Gene)FDA Link
12/2016 - 01/2002
8LigandsIBA
07/2015 - 06/2004
7Glycoproteins (Glycoprotein)IBA
04/2012 - 01/2004
5Galectin 4 (LGALS4)IBA
12/2016 - 04/2003
5G(M1) GangliosideIBA
02/2016 - 03/2005
4MucinsIBA
02/2016 - 05/2010
4Peptides (Polypeptides)IBA
07/2015 - 01/2004
4Cyclin-Dependent Kinase Inhibitor p16IBA
04/2013 - 07/2007
4Plant LectinsIBA
08/2012 - 07/2007
3N-Acetylneuraminic Acid (Sialic Acid)IBA
11/2012 - 12/2002
3IntegrinsIBA
04/2012 - 04/2005
3Carrier Proteins (Binding Protein)IBA
10/2011 - 08/2006
31-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
03/2011 - 11/2005
3Biomarkers (Surrogate Marker)IBA
08/2009 - 04/2005
3CollagenIBA
02/2009 - 11/2004
2Matrix Metalloproteinases (MMPs)IBA
10/2022 - 03/2010
2CytokinesIBA
12/2016 - 11/2004
2LactoseFDA LinkGeneric
10/2016 - 09/2009
2SolutionsIBA
03/2016 - 01/2004
2GlycopeptidesIBA
07/2015 - 12/2014
2Thomsen-Friedenreich antigenIBA
07/2015 - 12/2014
2AntibodiesIBA
03/2011 - 01/2002
2Retinal Pigments (Pigments, Visual)IBA
03/2011 - 10/2009
2Fibronectins (Fibronectin)IBA
03/2011 - 01/2011
2AntigensIBA
03/2010 - 08/2006
2Transforming Growth Factor beta (TGF-beta)IBA
07/2009 - 02/2009
2RicinIBA
01/2009 - 07/2008
2asialofetuinIBA
07/2008 - 04/2008
2Diethylstilbestrol (Stilbestrol)FDA Link
07/2006 - 01/2005
2Indicators and Reagents (Reagents)IBA
04/2005 - 10/2004
2GlycoconjugatesIBA
08/2004 - 11/2003
2GangliosidesIBA
12/2003 - 09/2003
1Cross-Linking ReagentsIBA
10/2022
1LipidsIBA
12/2016
1Peptide Hydrolases (Proteases)FDA Link
12/2016
1ProteomeIBA
12/2016
1GelsolinIBA
12/2016
1Ubiquitin-Conjugating EnzymesIBA
12/2016
1Epithelial Cell Adhesion MoleculeIBA
12/2016
1Calbindin 2IBA
12/2016
1Glutamine (L-Glutamine)FDA Link
12/2016
1KinesinsIBA
12/2016
1Lamin Type B (Lamin B)IBA
12/2016
1Heparin (Liquaemin)FDA LinkGeneric
10/2016
1Ethanol (Ethyl Alcohol)IBA
03/2016
1NAD (NADH)IBA
01/2016
1Tn antigenIBA
12/2014
1Galactose (Galactopyranose)FDA LinkGeneric
12/2014
1Butyric Acid (Butanoic Acid)IBA
10/2014
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
09/2014
1PolyaminesIBA
07/2014
1Amino AcidsFDA Link
03/2014
1Keratins (Keratin)IBA
02/2013
1Opsonin Proteins (Opsonins)IBA
01/2013
1Immunoglobulin G (IgG)IBA
01/2013
1AutoantibodiesIBA
01/2013

Therapy/Procedure

3Therapeutics
10/2016 - 08/2004
1Fluid Therapy (Oral Rehydration Therapy)
03/2016
1Transplantation
01/2016